Search results
McKinsey Boss’s Next Big Consulting Project: His Own Firm
The Wall Street Journal· 2 hours agoBUSINESS Soon after Bob Sternfels took the top job at the consulting giant McKinsey a few years ago,...
Denmark recalls Korean ramen for being too spicy
BBC via Yahoo News· 3 hours agoBut the maker Samyang says there's no problem with the quality of the food. "We understand that the Danish food authority recalled the products, not...
GameStop raises over $2bn after Roaring Kitty rally
BBC via Yahoo Finance· 15 hours agoThe firm said it had sold all 75 million shares it had offered to investors [Getty Images] US video game retailer GameStop says it has raised more than...
We've Got a New Price Target for Oracle After CEO Reveals Guidance
TheStreet.com· 2 hours agoOn Tuesday evening, software giant and number-four cloud computing services provider Oracle (ORCL)...
Trending tickers: Oracle, Apple, Paramount and L&G
Yahoo Finance UK· 9 hours agoSkydance Media, the firm behind Top Gun: Maverick, assembled a consortium of investors to buy the vehicle that owns Redstone’s controlling stake in...
AMD initiated, Paramount downgraded: Wall Street's top analyst calls
The Fly via Yahoo Finance· 5 hours agoTop 5 Upgrades: Citi upgraded McCormick (MKC) to Neutral from Sell with a price target of $69, up...
Terraform to Pay $4.47 Billion to Settle SEC Fraud Case
Bloomberg via Yahoo Finance· 1 hour ago(Bloomberg) -- Terraform Labs Pte. will pay $4.47 billion to resolve a US Securities and Exchange...
UTA Taps Bob Roback as Chief Operating Officer, Who Takes Over Role From Andrew Thau
Variety· 3 hours agoIn joining the firm, Roback will also be a partner and join UTA’s board of directors. Roback takes...
GameStop Stock Surges, Top Short Seller Bows Out On 'Mob Mentality'
Investor's Business Daily· 4 hours agoGME stock surged early Wednesday to add to its rally Tuesday. "Citron is no longer short GME," the ...
Canaccord maintains Buy rating on Akero stock, cites drug candidate 'Efruxifermin' By Investing.com
Investing.com· 6 hours agoOn Wednesday, Canaccord Genuity (TSX:CF) expressed continued optimism for Akero Therapeutics...